Johannes Gutenberg-Universität Mainz
- 6131/39-0
Luehr, Maximilian; Yildiz, Murat; Ma, Wei-Guo et al.
Acute type A aortic dissection in adolescents and young adults under 30 years of age: demographics, aetiology and postoperative outcomes of 139 casesEUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. Bd. 63. H. 5. 2023
Dohle, Daniel-Sebastian; Pfeiffer, Philipp; Probst, Chris et al.
Acute type I aortic dissection: 'is simultaneous descending stent grafting justified?'EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. Bd. 63. H. 6. 2023
Pham, Thu Nguyen Minh; Perumal, Natarajan; Manicam, Caroline et al.
Adaptive responses of neuronal cells to chronic endoplasmic reticulum (ER) stressREDOX BIOLOGY. Bd. 67. 2023
Melchior, Maria; Figueiredo, Natasha; Roversi, Aurelia et al.
Addressing mental health problems among persons without stable housing in the context of the COVID-19 pandemic: study protocol for a randomised trial. RESPOND - FranceBMC PUBLIC HEALTH. Bd. 23. H. 1. 2023
Mueller, Marcus; Turner, Daniel; Barra, Steffen et al.
ADHD and associated psychopathology in older adults in a German community sampleJOURNAL OF NEURAL TRANSMISSION. Bd. 130. H. 3. 2023 S. 313-323
Becker, Jan; Kreis, Adina; Schorch, Theresa et al.
Adherence and effectiveness of an emotion-based psychodynamic online self-help during and after inpatient and day-care psychotherapy: Results of a naturalistic studyFRONTIERS IN PSYCHIATRY. Bd. 14. 2023
Schmidt, Marcus; Nitz, Ulrike; Reimer, Toralf et al.
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate - The ICE randomized clinical trialEUROPEAN JOURNAL OF CANCER. Bd. 194. 2023
Thomssen, Christoph; Vetter, Martina; Kantelhardt, Eva J. J. et al.
Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology GroupCANCERS. Bd. 15. H. 5. 2023
Kirkwood, John; Del Vecchio, Michele; Weber, Jeffrey et al.
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trialNATURE MEDICINE. 2023
Kirkwood, John M.; Del Vecchio, Michele; Weber, Jeffrey et al.
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial (16 OCT, 10.1038/s41591-023-02583-2, 2023 )NATURE MEDICINE. 2023